Op-Ed Applauds Pharmaceutical Companies’ Dedication To Developing Ebola Vaccines.

John Lamattina writes in a contributor piece for Forbes (6/26) that large pharmaceutical companies such as Merck and Johnson & Johnson have been at the forefront of Ebola vaccine development efforts in the wake of the 2016 outbreak, which helped health a...